Needham & Company Downgrades Cardiovascular Systems (CSII) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P 500, Dow rise on Mideast deal hopes, SpaceX's historic debut
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil nears two-month lows on reports of imminent US-Iran peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
Cardiovascular Systems Reports Preliminary Fiscal First-Quarter Financial Results
October 7, 2015 4:00 PM EDTConference Call Scheduled for Today, Oct. 7, 2015, at 3:45 PM CT (4:45 PM ET)
Revenue is approximately $43.9 million, up 11 percent over prior-years first quarter, excluding Asahi guide wire sales in the prior period, but below guidance range Net loss is expected to be from $(0.41) to $(0.43) per common shareST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) today reported preliminary results for its fiscal 2016 first quarter ended September 30, 2015.
The company expects fiscal first-quarter revenues of approximately... More
